Transmitter unit for a glucose monitoring skin patch
Latest Verily Life Sciences LLC Patents:
- METHODS FOR DETECTING TUMOR DISEASE STATES USING CONJUGATES INCLUDING VOLATILE ORGANIC COMPOUNDS
- THIN-FILM LEAD ASSEMBLIES AND NEURAL INTERFACES
- Techniques for generating superresolution presentations of medical procedure video data
- SYSTEMS AND METHODS FOR ACTIVATING A CIRCUIT OF AN IMPLANT DEVICE
- Multidirectional periocular nerve stimulation and associated systems, devices, and methods
Description
The broken lines immediately adjacent the shaded areas represent the bounds of the claim, while all other broken lines are directed to environment; the broken lines form no part of the claimed design.
Claims
We claim the ornamental design for a transmitter unit for a glucose monitoring skin patch, as shown and described.
Referenced Cited
U.S. Patent Documents
Other references
| 9610031 | April 4, 2017 | Brister |
| D794201 | August 8, 2017 | Newhouse |
| 20130267811 | October 10, 2013 | Pryor |
| 20140276576 | September 18, 2014 | Cole |
| 20150209508 | July 30, 2015 | Constantineau |
| 20160058380 | March 3, 2016 | Lee |
| 20160157759 | June 9, 2016 | Yang |
| 20160287150 | October 6, 2016 | Yu |
| 20170112534 | April 27, 2017 | Schoonmaker |
| 20170188912 | July 6, 2017 | Halac |
- Bergan, Mark et al., “Dexcom Has a Big Ally if Apple Gets Into Its Corner of the Diabetes Market”, Bloomberg News, Apr. 19, 2017, Retrieved from the internet: https://www.bloomberg.com/news/articles/2017-04-19/dexcom-has-a-big-ally-if-apple-gets-into-its-corner-of-the-diabetes-market, 5 pages.
Patent History
Patent number: D816229
Type: Grant
Filed: Aug 25, 2017
Date of Patent: Apr 24, 2018
Assignee: Verily Life Sciences LLC (Mountain View, CA)
Inventors: Sean Frick (San Francisco, CA), Matthew D. Day (Oakland, CA), Maaike L. Evers (San Francisco, CA), Shannon C. Fong (San Francisco, CA), Arthur Lin (Fremont, CA)
Primary Examiner: Anhdao Doan
Application Number: 29/615,071
Type: Grant
Filed: Aug 25, 2017
Date of Patent: Apr 24, 2018
Assignee: Verily Life Sciences LLC (Mountain View, CA)
Inventors: Sean Frick (San Francisco, CA), Matthew D. Day (Oakland, CA), Maaike L. Evers (San Francisco, CA), Shannon C. Fong (San Francisco, CA), Arthur Lin (Fremont, CA)
Primary Examiner: Anhdao Doan
Application Number: 29/615,071
Classifications
Current U.S. Class:
Hematological Or Intravenous Treatment (41) (D24/169)